Macrophages Treated with VEGF and PDGF Exert Paracrine Effects on Olfactory Ensheathing Cell Function

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Spinal cord injury (SCI) presents a hostile environment for cell transplantation.
• Olfactory ensheathing cells (OECs) are a promising therapy for SCI.
• Macrophages in the SCI microenvironment can impede OEC integration and function.

Purpose of the Study:

• To investigate the effects of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) on macrophages.
• To determine if VEGF and PDGF can improve the phagocytic capacity of OECs.
• To assess the impact of growth factor-modulated macrophages on OEC gene expression related to nerve repair.

Main Methods:

• In vitro study of macrophages under inflammatory conditions.
• Treatment of macrophages with VEGF and PDGF, individually and in combination.
• Assessment of macrophage nuclear factor kappa B p65 translocation.
• Analysis of OEC phagocytosis of myelin debris using conditioned media.
• Gene expression analysis in OECs.

Main Results:

• Combined VEGF + PDGF reduced nuclear factor kappa B p65 translocation in macrophages without altering pro-inflammatory cytokines.
• Conditioned media from macrophages treated with PDGF or VEGF + PDGF enhanced OEC phagocytosis of myelin debris.
• Growth factor-treated conditioned media modulated OEC gene expression linked to nerve repair and myelin.

Conclusions:

• VEGF and PDGF can modulate macrophages in an inflammatory setting.
• Growth factor treatment of macrophages can enhance OEC phagocytic activity and promote nerve repair gene expression.
• Combining growth factors with OEC transplantation may represent a beneficial strategy for SCI therapy.